| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mendeliome v2.336 | NCOA1 | Zornitza Stark Marked gene: NCOA1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendeliome v2.336 | NCOA1 | Zornitza Stark Gene: ncoa1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendeliome v2.336 | NCOA1 | Zornitza Stark Classified gene: NCOA1 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendeliome v2.336 | NCOA1 | Zornitza Stark Gene: ncoa1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendeliome v2.335 | NCOA1 |
Zornitza Stark gene: NCOA1 was added gene: NCOA1 was added to Mendeliome. Sources: Literature Mode of inheritance for gene: NCOA1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: NCOA1 were set to 35137184; 30979869 Phenotypes for gene: NCOA1 were set to Inherited obesity, MONDO:0019182, NCOA1-related Review for gene: NCOA1 was set to AMBER Added comment: PMID 30979869 reports 16 individuals from 16 families and PMID 35137184 reports 47 individuals from 22 families with heterozygous NCOA1 missense variants presenting with severe early‑onset obesity (BMI SD > 3, onset < 10 y) often accompanied by hyperphagia, endocrine abnormalities (partial thyroid‑hormone resistance, menorrhagia) and bone fractures. Functional assays in PMID 30979869 demonstrate effects on STAT3‑POMC signalling, whereas PMID 35137184 provides a larger cohort lacking variant‑specific functional validation and includes several variants with population frequencies well above the monoallelic threshold. Many of the variants also lack segregation data. Hence Amber rating. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||